Annals of oncology : official journal of the European Society for Medical Oncology | Journament

Journal Ranking

#3719 / 33,980
📊 Below Average
Overall Score
41.2/100
Score Breakdown
Engagement
31
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
35
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
Updated 1 week ago

Annals of oncology : official journal of the European Society for Medical Oncology

Login or register to claim ownership or editorship of this journal.
Certificate of Indexing
Quality Widget - Embed on Your Website

Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.

One-Line JavaScript Embed (Recommended):
Advantages:
  • ✅ Simpler integration (just one line of code)
  • ✅ Better SEO (content is in same DOM)
  • ✅ No iframe limitations
  • ✅ Fully self-contained (no dependencies)
  • ✅ Works on any website regardless of CSS framework
  • ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
  • ⚠️ Display-only (scores not clickable due to iframe constraints)
  • ⚠️ May have SEO limitations
  • ⚠️ Potential CORS/CSP issues on some websites
Preview:
Indexings
ncbi
Short Name Ann Oncol
Abbreviated Name ann oncol
ISSN 0923-7534
Aim and Scope
URL https://www.sciencedirect.com/journal/annals-of-oncology
Author Instructions

Publications Per Year

Recent Articles (14 total)

2020
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
Fabi A;Bhargava R;Fatigoni S;Guglielmo M;Horneber M;Roila F;Weis J;Jordan K;Ripamonti CI; ;;
Vol. 31 , No. 6 , pp. -
588 views Abstract
2007
The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry
Delpech Y;Cortez A;Coutant C;Callard P;Uzan S;Darai E;Barranger E;;
Vol. 18 , No. 11 , pp. -
418 views Abstract
2019
A three-year study of epidemiological trends of gastrointestinal cancers in a Haitian cancer program.
Bernard, J;Gilbert, D;Germain, R;Alexis, L;DeGennaro, V;
Vol. 30 Suppl 4 , pp. iv20
361 views DOI
2019
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange, M;Joly, F;Vardy, J;Ahles, T;Dubois, M;Tron, L;Winocur, G;De Ruiter, M B;Castel, H;
Vol. 30 , No. 12 , pp. 1925-1940
358 views DOI Abstract
2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Jhaveri, K L;Wang, X V;Makker, V;Luoh, S-W;Mitchell, E P;Zwiebel, J A;Sharon, E;Gray, R J;Li, S;McShane, L M;Rubinstein, L V;Patton, D;Williams, P M;Hamilton, S R;Conley, B A;Arteaga, C L;Harris, L N;O'Dwyer, P J;Chen, A P;Flaherty, K T;
Vol. 30 , No. 11 , pp. 1821-1830
357 views DOI Abstract
2020
A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore.
Ngoi, Natalie;Lim, Joline;Ow, Samuel;Jen, Wei Ying;Lee, Matilda;Teo, Winnie;Ho, Jingshan;Sundar, Raghav;Tung, Moon Ley;Lee, Yee Mei;Ngo, Ednajoy;Lim, Siew Woon;Ong, Jason;Lim, Frances;Bonney, Glenn;Vellayappan, Balamurugan;Ho, Francis;Tey, Jeremy;Chan, Noreen;de Mel, Sanjay;Poon, Michelle;Lee, Shir Ying;Koh, Liang Piu;Liu, Te Chih;Tan, Lip Kun;Wong, Alvin;Wong, Andrea;Lim, Siew Eng;Yeoh, Allen;Wong, John El;Tan, David;Goh, Boon Cher;Chng, Wee Joo;Soo, Ross;Chee, Cheng Ean;Chee, Yen Lin;Lee, Soo Chin;Jeyasekharan, Anand D;, ;
346 views DOI
2016
Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned.
Friedlander, M;Mercieca-Bebber, R L;King, M T;
Vol. 27 Suppl 1 , pp. i66-i71
322 views DOI Abstract
2005
SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004.
Haie-Meder, C;Fervers, B;Fondrinier, E;Haugh, M;Lhomme, C;Guastalla, J P;
Vol. 16 , No. 7 , pp. 1100-8
321 views Abstract
2020
COVID-19 Infection in Cancer Patients: Early Observations and Unanswered Questions.
Oh, William K;
308 views DOI
2012
International models of investigator-initiated trials: implications for Japan.
Trimble, E L;Ledermann, J;Law, K;Miyata, T;Imamura, C K;Nam, B-H;Kim, Y H;Bang, Y-J;Michaels, M;Ardron, D;Amano, S;Ando, Y;Tominaga, T;Kurokawa, K;Takebe, N;
Vol. 23 , No. 12 , pp. 3151-3155
291 views DOI Abstract
View All 14 Articles
41
Overall
Below Average
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

41.2/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.9/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

35.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.